We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
52.00 | 5.16% | 1,060.00 | 1,050.00 | 1,056.00 | 1,056.00 | 1,014.00 | 1,030.00 | 1,351,449 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 18.04 | 755.85M |
TIDMCVSG
RNS Number : 3854W
CVS Group plc
31 July 2018
31 July 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that a total of 35,322 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 16 July 2018 as a result of the exercise of employee share options, in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) Save As You Earn Scheme. The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2017.
The Company also announces that 576 ordinary shares of 0.2 pence each were issued on 31 July 2018 as a result of the exercise of employee share options by former employees, in connection with the Company's December 2015 - December 2018 (January 2019 Maturity) Save As You Earn Scheme and 318 ordinary shares of 0.2 pence each were issued on 31 July 2018 as a result of the exercise of employee share options by former employees, in connection with the Company's December 2016 - December 2019 (January 2020 Maturity) Save As You Earn Scheme (together the "New Shares"). Application will be made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 7 August 2018.
Following issue of the SAYE Shares and the New Shares, the Company's total issued share capital is 70,370,420 ordinary shares of 0.2 pence each with one voting right per share. The Company does not hold any ordinary shares in Treasury. This figure of 70,370,420 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts: Tel: 01379 644 CVS Group plc 288 Simon Innes, Chief Executive Nick Perrin, Finance Director N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 Aubrey Powell 3000 Liz Yong
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TVRBLGDRCXXBGIB
(END) Dow Jones Newswires
July 31, 2018 12:45 ET (16:45 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions